Sign in to view content

BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)

Michael A. Singer, MD

Video
Published 2024

Related

Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa: Results from the Phase 2b Trial
Anthony Joseph, MD
Annual Meeting Talks
2020
Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa
Sai H Chavala, MD
On Demand Cases, Courses, and Papers
2021
Pericentral Retinitis Pigmentosa
Mauricio Bayram-Suverza, MD
Mark E Pennesi, MD/PhD
Retina Image Bank: Images of the Week
2024

Category: Hereditary Retinal Disease & Genetics

See more